Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
(Q74590600)
scientific article published on 01 March 1999
scientific article published on 01 March 1999
Language:
other details
| description | scientific article published on 01 March 1999 |
External Links
| (P356) |
10.1016/S0091-6749(99)70467-7
|
| (P698) |
10069876
|